A full 4-ton truckload of expanded polystyrene is reduced to one drum! This contributes to reducing transportation costs.
At Heimeltz, we offer a method that reduces 4-ton truckloads of expanded polystyrene into one drum canister. With one open drum, it is possible to reduce 70 kg of expanded polystyrene. Additionally, one pail can reduce 7 kg of expanded polystyrene. The gel-like product can be reduced to less than 1/100 of the volume of expanded polystyrene, allowing for significant reductions in transportation costs. 【Features】 ■ Can reduce expanded polystyrene to 1/100 of its apparent volume ■ Reduces expanded polystyrene and transportation costs ■ Large-scale equipment is not required for reduction ■ Can reduce any type of expanded polystyrene ■ Can be utilized as a recyclable product rather than waste *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Used expanded polystyrene material is reduced in volume with a special liquid. It can be started from tomorrow using only HM solvent. On-site, without machinery, bulky expanded polystyrene can be recycled instead of being disposed of as waste. This contributes not only to construction materials and cushioning materials but also to the reduction of marine PS plastic waste (such as expanded PS floats). The PS resin after volume reduction can be purchased by our company as raw material. Support is available from the nearest retailers nationwide (please consult regarding shipping costs, etc.). We at Heimeltz provide the best service as a company that contributes to a resource-circulating society through the recycling of expanded PS plastic, with a system that satisfies local communities and waste-generating businesses.
![[CPhI Seminar Report] Mutagenic Impurities in Pharmaceuticals (Active Pharmaceutical Ingredients)](https://image.mono.ipros.com/public/product/image/86f/2000714763/IPROS54094091646706511898.png?w=280&h=280)
